Ye J - Search Results

1

CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype.

Tan TZ, Yang H, Ye J, Low J, Choolani M, Tan DS, Thiery JP, Huang RY. Tan TZ, et al. Among authors: ye j. Oncotarget. 2015 Dec 22;6(41):43843-52. doi: 10.18632/oncotarget.5983. Oncotarget. 2015. PMID: 26549805 Free PMC article.

2

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.

Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S. Tan TZ, et al. Among authors: ye j. EMBO Mol Med. 2013 Jul;5(7):1051-66. doi: 10.1002/emmm.201201823. Epub 2013 May 13. EMBO Mol Med. 2013. PMID: 23666744 Free PMC article.

3

Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer.

Miow QH, Tan TZ, Ye J, Lau JA, Yokomizo T, Thiery JP, Mori S. Miow QH, et al. Among authors: ye j. Oncogene. 2015 Apr 9;34(15):1899-907. doi: 10.1038/onc.2014.136. Epub 2014 May 26. Oncogene. 2015. PMID: 24858042

4

Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response.

Rempel RE, Jiang X, Fullerton P, Tan TZ, Ye J, Lau JA, Mori S, Chi JT, Nevins JR, Friedman DR. Rempel RE, et al. Among authors: ye j. Mol Cancer Ther. 2014 Dec;13(12):3219-29. doi: 10.1158/1535-7163.MCT-13-0044. Epub 2014 Oct 27. Mol Cancer Ther. 2014. PMID: 25349303 Free PMC article.

5

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).

Huang RY, Kuay KT, Tan TZ, Asad M, Tang HM, Ng AH, Ye J, Chung VY, Thiery JP. Huang RY, et al. Among authors: ye j. Oncotarget. 2015 Sep 8;6(26):22098-113. doi: 10.18632/oncotarget.4300. Oncotarget. 2015. PMID: 26061747 Free PMC article.

6

GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.

Chung VY, Tan TZ, Tan M, Wong MK, Kuay KT, Yang Z, Ye J, Muller J, Koh CM, Guccione E, Thiery JP, Huang RY. Chung VY, et al. Among authors: ye j. Sci Rep. 2016 Feb 18;6:19943. doi: 10.1038/srep19943. Sci Rep. 2016. PMID: 26887977 Free PMC article.

7

Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer.

Tan TZ, Heong V, Ye J, Lim D, Low J, Choolani M, Scott C, Tan DSP, Huang RY. Tan TZ, et al. Among authors: ye j. J Pathol. 2019 Mar;247(3):305-319. doi: 10.1002/path.5191. Epub 2018 Dec 18. J Pathol. 2019. PMID: 30374975

8

The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma.

Tan M, Asad M, Heong V, Wong MK, Tan TZ, Ye J, Kuay KT, Thiery JP, Scott C, Huang RY. Tan M, et al. Among authors: ye j. Mol Oncol. 2019 Apr;13(4):757-780. doi: 10.1002/1878-0261.12425. Epub 2019 Jan 19. Mol Oncol. 2019. PMID: 30548372 Free PMC article.

9

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition.

Sundararajan V, Tan M, Tan TZ, Ye J, Thiery JP, Huang RY. Sundararajan V, et al. Among authors: ye j. Sci Rep. 2019 Jun 5;9(1):8295. doi: 10.1038/s41598-019-44826-8. Sci Rep. 2019. PMID: 31165775 Free PMC article.

10

The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.

Chung VY, Tan TZ, Ye J, Huang RL, Lai HC, Kappei D, Wollmann H, Guccione E, Huang RY. Chung VY, et al. Among authors: ye j. Commun Biol. 2019 Jul 24;2:272. doi: 10.1038/s42003-019-0506-3. eCollection 2019. Commun Biol. 2019. PMID: 31372511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,827 results

Search Page

Filters